सामग्री पर जाएँ

दवाओं की अंतःक्रिया

Insulin degludec + Pasireotide

गंभीरता: गंभीर

Insulin degludec and Pasireotide: major interaction.

अंतिम अपडेट

केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।

इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।

सारांश

Pasireotide frequently causes hyperglycemia and can markedly worsen glycemic control in diabetic patients. Insulin requirements may increase substantially.

इस इंटरैक्शन का सरल भाषा में अर्थ

Insulin degludec and Pasireotide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Insulin degludec belongs to Endocrine; Pasireotide belongs to Endocrine.

साक्ष्य स्तर: High

ऐसा क्यों होता है

Pasireotide suppresses insulin and incretin secretion (GLP-1 and GIP), producing hyperglycemia.

क्या करें

Check glucose before starting pasireotide and monitor frequently afterwards. Intensify insulin degludec as needed, and reduce the dose if pasireotide is stopped.

फार्मासिस्ट से क्या पूछें

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ सदस्यों के लिए

पूरा पेज खोलें

Insulin degludec और Pasireotide की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।

अक्सर पूछे जाने वाले प्रश्न

Can I take Insulin degludec with Pasireotide?

MediHelp rates the interaction as major. Insulin degludec and Pasireotide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Pasireotide frequently causes hyperglycemia and can markedly worsen glycemic control in diabetic patients. Insulin requirements may increase substantially.

How serious is the interaction between Insulin degludec and Pasireotide?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check glucose before starting pasireotide and monitor frequently afterwards. Intensify insulin degludec as needed, and reduce the dose if pasireotide is stopped.

What other medicines interact with Insulin degludec?

MediHelp also lists interactions of Insulin degludec with, for example, Alogliptin-pioglitazone, Ethanol, Glimepiride-pioglitazone. The full list is on the Insulin degludec page.

MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर

MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।

A–Z ब्राउज़ करें · दवाओं की अंतःक्रिया

ऐप पाएँ साइन इन